Roger Dobson. Show Affiliations »
Abstract
Mesh: See more » Clinical Trials as TopicCyclooxygenase 2 Inhibitors/adverse effectsHumansLactones/adverse effectsMyocardial Infarction/chemically inducedPeriodicals as TopicSulfones/adverse effects
Substances: See more » Cyclooxygenase 2 InhibitorsLactonesSulfonesrofecoxib
Year: 2006 PMID: 16840463 PMCID: PMC1502213 DOI: 10.1136/bmj.333.7559.116-f
Source DB: PubMed Journal: BMJ ISSN: 0959-8138